FABP4 knockdown suppresses inflammation, apoptosis and extracellular matrix degradation in IL-1β-induced chondrocytes by activating PPARγ to regulate the NF-κB signaling pathway

Mao,Huajie; Han,Bin; Li,Hao; Tao,Yiqing; Wu,Weigang

doi:10.3892/mmr.2021.12495

FABP4 knockdown suppresses inflammation, apoptosis and extracellular matrix degradation in IL-1β-induced chondrocytes by activating PPARγ to regulate the NF-κB signaling pathway

Authors:
- Huajie Mao
- Bin Han
- Hao Li
- Yiqing Tao
- Weigang Wu
View Affiliations

Affiliations: Department of Orthopedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, P.R. China
Published online on: October 14, 2021 https://doi.org/10.3892/mmr.2021.12495
Article Number: 855
Copyright: © Mao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoarthritis (OA) is a common degenerative disease that can lead to severe joint pain and loss of function, seriously threatening the health and normal life of patients. At present, the pathogenesis of OA remains to be clarified. Recent studies have shown that fatty acid‑binding protein 4 (FABP4) is increased in the plasma and synovial fluid of patients with OA. However, the effect of FABP4 on OA is unclear. The present study established IL‑1β‑induced ATDC5 cells with FABP4 knockdown. Next, cell viability was detected with Cell Counting Kit‑8 assay. The content of inflammatory factors, prostaglandin E2 and glycosaminoglycan (GAG) was detected via ELISA. The levels of reactive oxygen species (ROS) and superoxide dismutase (SOD) in cells were detected by using ROS and SOD kits, respectively. TUNEL staining was used to detect the apoptosis level. Western blotting was used to detect the expression levels of proteins. The results revealed that FABP4 was upregulated in IL‑1β‑induced ATDC5 cells. Knockdown of FABP4 increased cell viability, reduced inflammatory damage, oxidative stress and apoptosis in IL‑1β‑induced ATDC5 cells. Following FABP4 knockdown, the expression of matrix metalloproteinases (MMP3, MMP9 and MMP13) of IL‑1β‑induced ATDC5 cells was reduced, and the expression of GAG was promoted. FABP4 knockdown also inhibited the expression of NF‑κB p65 and enhanced peroxisome proliferator‑activated receptor (PPAR)γ expression. However, the presence of PPARγ inhibitor blocked the aforementioned effects of FABP4 on IL‑1β‑induced ATDC5 cells. In conclusion, FABP4 knockdown suppressed the inflammation, oxidative stress, apoptosis and extracellular matrix degradation of IL‑1β‑induced chondrocytes by activating PPARγ to inhibit the NF‑κB signaling pathway.

View Figures

View References

1	McAlindon TE and Bannuru RR: OARSI recommendations for the management of hip and knee osteoarthritis: The semantics of differences and changes. Osteoarthritis Cartilage. 18:473–475. 2010. View Article : Google Scholar : PubMed/NCBI
2	Bian Q, Wang YJ, Liu SF and Li YP: Osteoarthritis: Genetic factors, animal models, mechanisms, and therapies. Front Biosci (Elite Ed). 4:74–100. 2012. View Article : Google Scholar : PubMed/NCBI
3	Moon KH: New view on the initial development site and radiographic classification system of osteoarthritis of the knee based on radiographic analysis. Int J Biomed Sci. 8:233–243. 2012.PubMed/NCBI
4	Troeberg L and Nagase H: Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta. 1824:133–145. 2012. View Article : Google Scholar : PubMed/NCBI
5	Boehme KA and Rolauffs B: Onset and Progression of Human Osteoarthritis-Can Growth Factors, Inflammatory Cytokines, or Differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage? Int J Mol Sci. 19:22822018. View Article : Google Scholar : PubMed/NCBI
6	Wang Y, Ding L, Yang J, Liu L and Dong L: Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes. PeerJ. 9:e108002021. View Article : Google Scholar : PubMed/NCBI
7	Sung CH, Hsu BG, Tasi JP, Wang CH and Kuo CH: Positive Associations between Adipocyte Fatty Acid-Binding Protein Level and Central Arterial Stiffness in Peritoneal Dialysis Patients. Int J Hypertens. 2021:88491152021. View Article : Google Scholar : PubMed/NCBI
8	Lei C, Li M, Zhang M, Wang S, Tian J, Wen J and Li Y: Cloning, molecular characterization, and nutritional regulation of fatty acid-binding protein family genes in gold pompanos (Trachinotus ovatus). Comp Biochem Physiol B Biochem Mol Biol. 246-247:1104632020. View Article : Google Scholar : PubMed/NCBI
9	Hotamisligil GS and Bernlohr DA: Metabolic functions of FABPs - mechanisms and therapeutic implications. Nat Rev Endocrinol. 11:592–605. 2015. View Article : Google Scholar : PubMed/NCBI
10	Yao F, Jiang DD, Guo WH, Guo LS, Gao MM, Bai Y, Wang X and Zhang LS: FABP4 inhibitor attenuates inflammation and endoplasmic reticulum stress of islet in leptin receptor knockout rats. Eur Rev Med Pharmacol Sci. 24:12808–12820. 2020.PubMed/NCBI
11	Ge XN, Bastan I, Dileepan M, Greenberg Y, Ha SG, Steen KA, Bernlohr DA, Rao SP and Sriramarao P: FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol. 315:L227–L240. 2018. View Article : Google Scholar : PubMed/NCBI
12	Gong Y, Yu Z, Gao Y, Deng L, Wang M, Chen Y, Li J and Cheng B: FABP4 inhibitors suppress inflammation and oxidative stress in murine and cell models of acute lung injury. Biochem Biophys Res Commun. 496:1115–1121. 2018. View Article : Google Scholar : PubMed/NCBI
13	Furuhashi M: Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases. J Atheroscler Thromb. 26:216–232. 2019. View Article : Google Scholar : PubMed/NCBI
14	Zhang C, Li T, Chiu KY, Wen C, Xu A and Yan CH: FABP4 as a biomarker for knee osteoarthritis. Biomarkers Med. 12:107–118. 2018. View Article : Google Scholar : PubMed/NCBI
15	Gu HY, Yang M, Guo J, Zhang C, Lin LL, Liu Y and Wei RX: Identification of the Biomarkers and Pathological Process of Osteoarthritis: Weighted Gene Co-expression Network Analysis. Front Physiol. 10:2752019. View Article : Google Scholar : PubMed/NCBI
16	Schadler P, Lohberger B, Thauerer B, Faschingbauer M, Kullich W, Stradner MH, Husic R, Leithner A and Steinecker-Frohnwieser B: Fatty Acid-Binding Protein 4 (FABP4) Is Associated with Cartilage Thickness in End-Stage Knee Osteoarthritis. Cartilage. 194760352110115202021.PubMed/NCBI
17	Huang TL, Yang CH, Yanai G, Liao JY, Sumi S and Yang KC: Synergistic effect of l-ascorbic acid and hyaluronic acid on the expressions of matrix metalloproteinase-3 and −9 in human chondrocytes. J Biomed Mater Res B Appl Biomater. 106:1809–1817. 2018. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Brown KA, Davidson EJ, Johnson AL, Wulster KB and Ortved K: Inflammatory cytokines in horses with cervical articular process joint osteoarthritis on standing cone beam computed tomography. Equine Vet J. 2020.PubMed/NCBI
20	Hwang HS, Park IY, Kim DW, Choi SY, Jung YO and Kim HA: PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model. BMB Rep. 48:407–412. 2015. View Article : Google Scholar : PubMed/NCBI
21	Zhi LQ, Yao SX, Liu HL, Li M, Duan N and Ma JB: Hydroxytyrosol inhibits the inflammatory response of osteoarthritis chondrocytes via SIRT6-mediated autophagy. Mol Med Rep. 17:4035–4042. 2018.PubMed/NCBI
22	Zhang Y, Huang X and Yuan Y: Anti-inflammatory capacity of Apremilast in human chondrocytes is dependent on SOX-9. Inflamm Res. 69:1123–1132. 2020. View Article : Google Scholar : PubMed/NCBI
23	Oliviero F, Ramonda R, Scanu A, Galozzi P, Favero M and Punzi L: Levels of inflammatory cytokines and metalloproteinases are increased in knee synovial fluid of patients with concomitant erosive hand osteoarthritis. Clin Exp Rheumatol. 38:8002020.PubMed/NCBI
24	Deng Z, Zhang R, Li M, Wang S, Fu G, Jin J, Wang Z, Ma Y and Zheng Q: STAT3/IL-6 dependent induction of inflammatory response in osteoblast and osteoclast formation in nanoscale wear particle-induced aseptic prosthesis loosening. Biomater Sci. 9:1291–1300. 2021. View Article : Google Scholar : PubMed/NCBI
25	Yang TTCC, Chen CL, Lin WC, Lin YS, Tseng PC, Hsieh CY, Chen YH, Huang WC, Tsai CC, Wang CY, et al: Glycogen synthase kinase-3β inactivation is an intracellular marker and regulator for endotoxemic neutrophilia. J Mol Med (Berl). 91:207–217. 2013. View Article : Google Scholar : PubMed/NCBI
26	Solovykh EA, Karaoglanova TB, Kushlinskii NE and Yanushevich OO: Matrix metalloproteinases and inflammatory cytokines in the oral fluid of patients with chronic generalized periodontitis various structural materials restoration of teeth and dentition. Klin Lab Diagn. 55-58:18–21. 2013.(In English, Russian). PubMed/NCBI
27	Hwang HS and Kim HA: Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis. Int J Mol Sci. 16:26035–26054. 2015. View Article : Google Scholar : PubMed/NCBI
28	Ding W, Du D and Chen S: LIPUS promotes synthesis and secretion of extracellular matrix and reduces cell apoptosis in human osteoarthritis through upregulation of SOX9 expression. Int J Clin Exp Pathol. 13:810–817. 2020.PubMed/NCBI
29	Gepstein A, Arbel G, Blumenfeld I, Peled M and Livne E: Association of metalloproteinases, tissue inhibitors of matrix metalloproteinases, and proteoglycans with development, aging, and osteoarthritis processes in mouse temporomandibular joint. Histochem Cell Biol. 120:23–32. 2003. View Article : Google Scholar : PubMed/NCBI
30	Wen Y, Qin J, Deng Y, Wang H, Magdalou J and Chen L: The critical role of UDP-galactose-4-epimerase in osteoarthritis: Modulating proteoglycans synthesis of the articular chondrocytes. Biochem Biophys Res Commun. 452:906–911. 2014. View Article : Google Scholar : PubMed/NCBI
31	Slovacek H, Khanna R, Poredos P, Jezovnik M, Hoppensteadt D, Fareed J and Hopkinson W: Interrelationship of Osteopontin, MMP-9 and ADAMTS4 in Patients With Osteoarthritis Undergoing Total Joint Arthroplasty. Clin Appl Thromb Hemost. 26:10760296209648642020. View Article : Google Scholar : PubMed/NCBI
32	Ojanen SP, Finnilä MAJ, Reunamo AE, Ronkainen AP, Mikkonen S, Herzog W, Saarakkala S and Korhonen RK: Site-specific glycosaminoglycan content is better maintained in the pericellular matrix than the extracellular matrix in early post-traumatic osteoarthritis. PLoS One. 13:e01962032018. View Article : Google Scholar : PubMed/NCBI
33	Mehana EE, Khafaga AF and El-Blehi SS: The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci. 234:1167862019. View Article : Google Scholar : PubMed/NCBI
34	Garin-Shkolnik T, Rudich A, Hotamisligil GS and Rubinstein M: FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues. Diabetes. 63:900–911. 2014. View Article : Google Scholar : PubMed/NCBI
35	Wang JS, Xiao WW, Zhong YS, Li XD, Du SX, Xie P, Zheng GZ and Han JM: Galectin-3 deficiency protects lipopolysaccharide-induced chondrocytes injury via regulation of TLR4 and PPAR-γ-mediated NF-κB signaling pathway. J Cell Biochem. 120:10195–10204. 2019. View Article : Google Scholar : PubMed/NCBI
36	Kobayashi T, Notoya K, Naito T, Unno S, Nakamura A, Martel-Pelletier J and Pelletier JP: Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs. Arthritis Rheum. 52:479–487. 2005. View Article : Google Scholar : PubMed/NCBI
37	Rigoglou S and Papavassiliou AG: The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 45:2580–2584. 2013. View Article : Google Scholar : PubMed/NCBI
38	Jia T, Cai M, Ma X, Li M, Qiao J and Chen T: Oridonin inhibits IL-1β-induced inflammation in human osteoarthritis chondrocytes by activating PPAR-γ. Int Immunopharmacol. 69:382–388. 2019. View Article : Google Scholar : PubMed/NCBI
39	Qu Y, Zhou L and Wang C: Mangiferin Inhibits IL-1β-Induced Inflammatory Response by Activating PPAR-γ in Human Osteoarthritis Chondrocytes. Inflammation. 40:52–57. 2017. View Article : Google Scholar : PubMed/NCBI